Our firm advised Entero Healthcare Solutions Limited ("Entero") and OrbiMed Asia III Mauritius Limited, Prabhat Agrawal, and Prem Sethi, (the "Promoter Selling Shareholders"), on the initial public offering ("IPO") The IPO comprised of a fresh issue aggregating to INR 10,000 million and an offer for sale aggregating to INR 6,000 million by certain selling shareholders which was well oversubscribed.1

Entero has been recognised as one of the top three healthcare products distributors in India terms of its revenue and also achieved the fastest scale-up of operations among healthcare distributors in India.

Deal amount: INR 16,000 million / USD 192.75 million (approx.)

Book Runing Lead Managers to the IPO ("BRLMs"): ICICI Securities Limited, DAM Capital Advisors Limited, Jefferies India Private Limited, JM Financial Limited, and SBI Capital Markets Limited

INDUSLAW Team:

Entero: Manan Lahoty (Partner), Ravi Dubey (Partner), Priyadarshini Rao (Partner), Ayushi Tiwari (Associate), Sachin Santuka (Associate), Abishek Sankar (Associate), Bhaskar Kumar (Associate), Aniruddh Saraswat (Associate), and Arjun Badola (Associate).

Promoter Selling Shareholders: Manshoor Nazki (Partner) and Anshul Roy (Partner)

Other law firms involved:

  • Domestic legal counsel to BRLMs: Trilegal
  • International legal counsel to BRLMs: Sidley Austin LLP

Footnotes

1 https://www.ndtvprofit.com/ipos/entero-healthcare-solutions-ipo-subscription-day-3-live-updates

2 https://www.moneycontrol.com/news/business/ipo/entero-healthcare-solutions-raises-rs-716-crore-from-anchor-investors-ahead-of-ipo-12226731.html

3 https://economictimes.indiatimes.com/markets/expert-view/massive-growth-opportunities-for-healthcare-industry-in-india-entero-healthcare-md/articleshow/107584269.cms?from=mdr